Latest News About Novo Nordisk A/S - Site Bagsværd (Nn1)

Updated 2026-05-06 12:05

I don’t have live access to current news feeds in this moment. Here’s a concise plan to get you the latest on Novo Nordisk A/S, Bagsværd (NN1):

Would you like me to fetch and summarize the latest items now, and provide citations after each claim? If you have a preferred news source (e.g., Novo Nordisk newsroom, Reuters, Bloomberg), tell me and I’ll prioritize it.

Sources

Novo Nordisk A/S

Danish drugmaker Novo Nordisk plans to invest 8.5 billion Danish kroner (about €1.14 billion) to establish a new production facility in Odense, Denmark. News … Novo Nordisk wants to make another major capital investment in production capacity for its diabetes and obesity therapies. The Danish drugmaker announced to spend more than 16 billion Danish kroner (€2.1 billion euros) starting in 2023 to expand its production site in Chartres, France, adding aseptic production and finished production...

chemanager-online.com

Novo Nordisk

Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases.

www.novonordisk.com

Novo Nordisk A/S | Globenewswire

Novo Nordisk A/S: The acquisition of Catalent by Novo Holdings, and the related acquisition by Novo Nordisk of three manufacturing sites from Novo Holdings, is cleared to close

via.ritzau.dk

Newsroom | Novo Nordisk

Here journalists can access a concise and up-to-date overview of our company’s key facts, figures, and milestones.

www.novonordisk.com

Novo Nordisk A/S | Globenewswire - Via Ritzau

Novo Nordisk A/S: The acquisition of Catalent by Novo Holdings, and the related acquisition by Novo Nordisk of three manufacturing sites from Novo Holdings, is cleared to close

via.ritzau.dk